Cure My Disease

Don't miss your cure!

 Log in / Sign up

New sensor sniffs out how wounds heal

NCT ID NCT06944899

Knowledge-focused Sponsor: Stephen Badylak Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special sensor that measures nitric oxide (NO) levels in open wounds. Researchers think NO levels can show how well a wound is healing. Ten adults with muscle loss injuries had the sensor placed in their wound for 30-60 minutes, then had follow-up visits to track healing. The goal was to see if the sensor works and can help doctors understand wound healing better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10 people

The number who actually took part.

Started

May 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Extremity injury 2. Wound surface area 2-10 cm in diameter 3. Wound amenable to NO Sensor placement 4. Age at the time of consent ≥ 22 to ≤ 65 years 5. Cognitively able to undergo informed consent discussion and understand the study Exclusion Criteria: 1. Chemotherapy 2. Pregnancy 3. Preexisting immunosuppressive conditions or immunosuppression therapy 4. Active hemorrhage in the wound bed 5. Physician discretion for patients with complex medical conditions or high mortality risks 6. Patients with an active implanted device, such as a pacemaker, defibrillator, or hypoglossal or vagal nerve stimulator 7. Patients requiring a legally authorized representative (LAR) for informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Volumetric muscle loss are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

muscular atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Volumetric muscle loss

Contacts and locations

Locations

  • UPMC Mercy

    Pittsburgh, Pennsylvania, 15219, United States